Clinical Trial Update: Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating neoadjuvant versus adjuvant therapy for resectable thoracic esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN